125 related articles for article (PubMed ID: 37837242)
1. Claudin-4 immunocytochemistry is specific and sensitive for the diagnosis of malignant carcinomatous effusions: Results from a pilot study.
Hruaii V; Thirunavukkarasu B; Prabha V; Mathur S; Iyer VK; Nambirajan A; Jain D
Diagn Cytopathol; 2024 Jan; 52(1):30-41. PubMed ID: 37837242
[TBL] [Abstract][Full Text] [Related]
2. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
3. Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.
Patel A; Borczuk AC; Siddiqui MT
J Am Soc Cytopathol; 2020; 9(3):146-151. PubMed ID: 32184064
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.
Elhosainy A; Hafez MMA; Yassin EH; Adam M; Elnaggar MS; Aboulhagag NA
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2779-2785. PubMed ID: 36037134
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions.
Mangla G; Bakshi P; Agarwal P; Verma K
Acta Cytol; 2023; 67(5):564-572. PubMed ID: 37331346
[TBL] [Abstract][Full Text] [Related]
6. The "Brescia panel" (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas.
Bernardi L; Bizzarro T; Pironi F; Szymczuk S; Buda R; Fabbri E; Di Claudio G; Rossi G
Cancer Cytopathol; 2021 Apr; 129(4):275-282. PubMed ID: 33045147
[TBL] [Abstract][Full Text] [Related]
7. Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimens.
Vojtek M; Walsh MD; Papadimos DJ; Shield PW
Cytopathology; 2019 Nov; 30(6):614-619. PubMed ID: 31390089
[TBL] [Abstract][Full Text] [Related]
8. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.
Facchetti F; Lonardi S; Gentili F; Bercich L; Falchetti M; Tardanico R; Baronchelli C; Lucini L; Santin A; Murer B
Virchows Arch; 2007 Sep; 451(3):669-80. PubMed ID: 17609977
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Usefulness of Claudin-3 and Claudin-4 for Immunocytochemical Differentiation between Metastatic Adenocarcinoma Cells and Reactive Mesothelial Cells in Effusion Cell Blocks.
Kim NI; Kim GE; Lee JS
Acta Cytol; 2016; 60(3):232-9. PubMed ID: 27387183
[TBL] [Abstract][Full Text] [Related]
10. The application of immunocytochemistry to direct smears in the diagnosis of effusions.
Knoepp SM; Placido J; Fields KL; Thomas D; Roh MH
Diagn Cytopathol; 2013 May; 41(5):425-30. PubMed ID: 22549950
[TBL] [Abstract][Full Text] [Related]
11. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
12. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
14. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.
Hanna A; Pang Y; Bedrossian CW; Dejmek A; Michael CW
Diagn Cytopathol; 2010 Apr; 38(4):264-9. PubMed ID: 20146302
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels.
Sridakhun N; Intarawichian P; Thanee M; Watcharadetwittaya S
Acta Cytol; 2023; 67(3):257-264. PubMed ID: 36513033
[TBL] [Abstract][Full Text] [Related]
17. The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens.
Najjar S; Gan Q; Stewart J; Sneige N
Cancer Cytopathol; 2023 Apr; 131(4):245-253. PubMed ID: 36522809
[TBL] [Abstract][Full Text] [Related]
18. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
[TBL] [Abstract][Full Text] [Related]
19. Identifying the primary site of malignancy in carcinomatous serous effusions using immunocytochemistry.
Kundu R; Parwaiz A; Gupta P; Rohilla M; Gupta N; Srinivasan R; Dey P
Cytopathology; 2022 Nov; 33(6):678-687. PubMed ID: 35749049
[TBL] [Abstract][Full Text] [Related]
20. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]